These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5220251)

  • 1. Glycogen storage disease treated by portacaval transposition.
    Ridell AG; Davies RP
    Proc R Soc Med; 1966 Jun; 59(6):484. PubMed ID: 5220251
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 3. Portal diversion in glycogen storage disease.
    Starzl TE; Brown BI; Blanchard H; Brettschneider L
    Surgery; 1969 Mar; 65(3):504-6. PubMed ID: 4303854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Portal shunts in metabolic liver diseases].
    Bismuth H; Franco D; Grange D
    Gastroenterol Clin Biol; 1977; 1(11):903-16. PubMed ID: 340317
    [No Abstract]   [Full Text] [Related]  

  • 5. Portacaval shunt in the treatment of glycogen storage disease: report of a case.
    Hermann RE; Mercer RD
    Surgery; 1969 Mar; 65(3):499-503. PubMed ID: 5250067
    [No Abstract]   [Full Text] [Related]  

  • 6. Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery.
    Folkman J; Philippart A; Tze WJ; Crigler J
    Surgery; 1972 Aug; 72(2):306-14. PubMed ID: 4626293
    [No Abstract]   [Full Text] [Related]  

  • 7. Portal diversion for the treatment of glycogen storage disease in humans.
    Starzl TE; Putnam CW; Porter KA; Halgrimson CG; Corman J; Brown BI; Gotlin RW; Rodgerson DO; Greene HL
    Ann Surg; 1973 Oct; 178(4):525-39. PubMed ID: 4517839
    [No Abstract]   [Full Text] [Related]  

  • 8. Portal diversion. Treatment for glycogen storage disease and hyperlipemia.
    Starzl TE; Putnam CW
    JAMA; 1975 Sep; 233(9):955-7. PubMed ID: 168416
    [No Abstract]   [Full Text] [Related]  

  • 9. Portacaval transposition in the treatment of glycogen-storage disease.
    Riddell AG; Davies RP; Clark AD
    Lancet; 1966 Nov; 2(7474):1146-8. PubMed ID: 4162539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surgical therapy of metabolic liver diseases (glycogenosis, hypercholesterolemia)].
    Meriggi F; Forni E; Bismuth H
    G Chir; 1998 Mar; 19(3):79-84. PubMed ID: 9577079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.
    Burr IM; O'Neill JA; Karzon DT; Howard LJ; Greene HL
    J Pediatr; 1974 Dec; 85(6):792-5. PubMed ID: 4213651
    [No Abstract]   [Full Text] [Related]  

  • 12. Portacaval shunt for glycogen storage disease and hyperlipidaemia.
    Starzl TE; Putnam CW; Porter KA; Benichou J
    Ciba Found Symp; 1977; (55):311-25. PubMed ID: 207496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.
    STARZL TE; MARCHIORO TL; SEXTON AW; ILLINGWORTH B; WADDELL WR; FARIS TD; HERRMANN TJ
    Surgery; 1965 May; 57():687-97. PubMed ID: 14295780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surgical management of hepatic type glycogenosis--anastomosis of the mesenteric vein and the inferior vana cava].
    Kozaka S; Nishio I; Bando H; Miwa K; Namba I
    Shujutsu; 1968 Aug; 22(8):757-63. PubMed ID: 5249138
    [No Abstract]   [Full Text] [Related]  

  • 15. LIVER DEGLYCOGENATION AFTER PORTACAVAL TRANSPOSITION.
    SEXTON AW; MARCHIORO TL; WADDELL WR; STARZL TE
    Surg Forum; 1964; 15():120-2. PubMed ID: 14189279
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of portacaval transposition on renal hypertension in the dog.
    Schwartz DT; McCabe RE; Zintel HA
    Surg Gynecol Obstet; 1966 Feb; 122(2):317-25. PubMed ID: 5901299
    [No Abstract]   [Full Text] [Related]  

  • 17. The ripple effect of liver transplantation.
    Starzl TE
    Transplant Proc; 1980 Dec; 12(4):626-33. PubMed ID: 7010724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of neutropenia by portacaval shunt in type IB glycogen storage disease.
    J Pediatr; 1982 Jan; 100(1):168-9. PubMed ID: 6948944
    [No Abstract]   [Full Text] [Related]  

  • 19. [Portacaval shunt associated with arterialization of portal vein: an experimental study in cirrhotic rats].
    Yang GS
    Zhonghua Wai Ke Za Zhi; 1983 Dec; 21(12):724-7. PubMed ID: 6676026
    [No Abstract]   [Full Text] [Related]  

  • 20. Arterialization of the liver after portacaval shunt in the rabbit.
    Vassanelli P; Zannini P; Merigliano S; Maruotti RA
    Int Surg; 1980; 65(2):151-5. PubMed ID: 7216658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.